{"cdcTestId":"2013-0509","testcaseName":"# 1 at age 15 years","vaccineGroup":"MCV","evaluationTestType":"All Valid: Forecast Test","forecastTestType":"Recommended based on age","assessmentDate":"2022-10-19T00:00:00","patient":{"dob":"2007-10-11T00:00:00","gender":"F"},"evaluation":{"seriesStatus":"Not complete","administeredDoses":[{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"meningococcal MCV4, unspecified formulation","cvx":"147","mvx":"","evaluationStatus":"Valid","evaluationReason":null}]},"forecast":{"forecastNum":"2","earliestDate":"2023-10-11T00:00:00","recommendedDate":"2023-10-11T00:00:00","pastDueDate":"2024-11-07T00:00:00"},"doses":[{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"meningococcal MCV4, unspecified formulation","cvx":"147","mvx":"","evaluationStatus":"Valid","evaluationReason":null}],"dateAdded":"2013-01-01T00:00:00","dateUpdated":"2020-06-01T12:22:42.137","generalDescription":"This test case describes when the first dose of a Mening vaccine is administered at 15 years \u002B 8 days, that the dose is considered to be valid.","changedInVersion":"1.6","reasonForChange":"v1.6: An EIPB clarification has resulted in a change to when dose 2 of MCV should be forecasted and validated.  The second dose must come on or after 16 years (- 4 days) of age to be considered valid."}